A New Treatment for Stage 4 Metastatic Prostate Cancer

Dr. Michael Morris, MD, Prostate Cancer Section Head at MSK, explains the use of theranostics as a new treatment for people with stage 4 metastatic prostate cancer.

Learn more about MSK: https://www.mskcc.org

CONNECT WITH MSK
o Facebook:   / memorialsloankettering  
o X: https://x.com/mskcancercenter
o Instagram:   / memorialsloankettering  
o LinkedIn:   / memorial-sloan-kettering-cancer-center